Prof. Dyah Aryani Perwitasari
https://orcid.org/0000-0002-2638-6664
Universitas Ahmad Dahlan, Indonesia
SCOPUS: https://www.scopus.com/authid/detail.uri?authorId=36114858900
H-Index: 17
Other social media:
https://scholar.google.co.id/citations?user=Ii5rp1EAAAAJ&hl=en
Dr. Dyah A Perwitasari, Apt., Ph.D. was born in Semarang, on April 30, 1976, NIDN and NIY Obtained her degree from the University of Semarang. April 30, 1976, NIDN 0530047601 and NIY 60010301 Obtained her undergraduate degree from Faculty of Pharmacy UGM, a master's degree in Clinical Pharmacy from Master of PharmacyClinical Pharmacy UGM, doctoral degree in pharmacoepidemiology and pharmacogenetics from Faculty of Medicine UGM (2011) and Dept. Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden The Netherlands (2012). Recent publication topics and most popular publication topic is ABCB1, CYP2D6 and 5HT3B polymorphisms in cancer patients in Indonesia published in International Journal of Biological Markers and Japannese Journal of Clinical Oncology. of Clinical Oncology. Publication on the validation of the Indonesian version of EORTC QLQ C30 in the Japannese Journal of Clinical Oncology and Quality of Life of cancer patients in Indonesia in the International Journal of Gynaecological Cancer. Publication on the validation of SF 36 and St George Respiratory Questionnaire in international seminars. Field of research is currently developed is research on the quality of life of as an outcome of therapy, pharmacogenetics, pharmacoepidemiology and pharmacovigilance. pharmacovigilance. Participation in international organizations are: International Society of Pharmacoepidemiology, the International Society of Pharmacoeconomic and Outcome Research and International Society of Pharmacovigilance. participation in international conferences in 2013 include Phillipine Pharmacists Summit in Manila, Asia Conference of Clinical Pharmacy in Vietnam, International Conference of Pharmacoepidemiology in Montreal, Canada and International Conference of Pharmacovigilance in Pisa, Italy.
Research interest: Clinical Pharmacy; Pharmacogenetic; Pharmaciepidemiology; Pharmacoeconomic